HHS AI Use Case Inventory 2024
The Office of the Assistant Secretary for Technology Policy’s (ASTP) Office of the Chief Artificial Intelligence Officer (OCAIO) is responsible for leading the annual HHS AI use case inventory.
This artificial intelligence (AI) use case publication requirement was first initiated by President Trump through Executive Order 13960 “Promoting the Use of Trustworthy Artificial Intelligence in the Federal Government” and further enhanced by President Biden’s Executive Order 14110 "Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence.” The Office of Management and Budget (OMB) Memoranda M-24-10 “Advancing Governance, Innovation, and Risk Management for Agency Use of Artificial Intelligence” establishes requirements and guidance for AI governance, innovation, and risk management.
Questions can be directed to HHS.CAIO@hhs.gov.
| Use Case Name | Stage of System Dev Life Cycle | Op Div/Staff Div |
|---|---|---|
| Augmenting death and cause of death ascertainment in observational data sources | Operation and Maintenance | FDA |
| CLAT (Computerized Labeling Assessment Tool) | Acquisition and/or Development | FDA |
| Empirical evaluation of EHR-based signal detection approaches | Acquisition and/or Development | FDA |
| FAR-based Facility Signal Detection Tool | Operation and Maintenance | FDA |
| MedWatch Dashboard | Operation and Maintenance | FDA |
| Quality Surveillance Dashboard (QSD) | Operation and Maintenance | FDA |
| Scalable automated NLP-assisted chart abstraction and feature extraction tool | Acquisition and/or Development | FDA |
| Annual Report CMC | Operation and Maintenance | FDA |
| Application-DMF Reference | Operation and Maintenance | FDA |
| Artificial Intelligence-based Deduplication Algorithm for Classification of Duplicate Reports in the FDA Adverse Event Reports (FAERS) | Implementation and Assessment | FDA |